EU Regulators Warn of Counterfeit Copies of Cancer Drug Herceptin
EU regulators have issued a warning that several batches of the cancer medicine Herceptin (trastuzumab) have been “tampered with,” falsified and reintroduced into the supply chain, potentially putting patients at risk.
High-cost cancer medications like Herceptin have become an increasingly tempting target for thieves and counterfeiters in recent years. While they lack the ready market that some drugs like Viagra have, their extraordinary cost means extraordinary paydays. US officials warned of a similar scare in February 2012, when counterfeit copies of Roche’s Avastin (bevacizumab) were found to have infiltrated the US supply chain. Another batch of the counterfeit drug was found in April 2012.
In the wake of those findings, FDA went after more than a dozen physicians, who were blamed for purchasing the Avastin from unauthorized suppliers in the pursuit of higher profit margins.
Related Posts
NYC debates crackdown on counterfeit luxury goods
Bargain hunters from around the world flock to Manhattan's Chinatown for bags,...
Police must do more to stem counterfeit & illicit trade
Local industries, particularly those in the manufacturing and import sectors,...
Customs Intercepts N9m Fake Malaria Drugs In Edo
The Federal Operations Unit, zone C, of the Nigeria Customs Service (NCS), has...
Black market for illicit tobacco in Devon and Cornwall puts squeeze on already hard-pressed families
A black market in illicit tobacco is engulfing Devon and Cornwall, funding...